The dual face of lamin A/C cardiomyopathy: risk prediction of heart failure and arrhythmias

sponsorship: S.H. has received funding from the European Union Commission's Seventh Framework programme under grant agreement no. 305507 (HOMAGE) and acknowledges the support of Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821508. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA; European Innovation Council (EIC) HORIZON-EIC-2022-PATHFINDERCHALLENGES. Grant agreement ID: 101115416; ZonMW Netherlands Metacor project, grant number 09120012110086. NWO and Dutch Heart Foundation DCM Precise, KIC - DEMAND Partnership NWO - Hartstichting, File number KICH2.V4P.HS23.100/ Budget no. 22044; Dutch National CardioResource, Grant ID https://doi.org/10.61686/ZVRAV31213. S.H. is a member of the European Reference Network for rare low prevalence and complex diseases of the heart-ERN GUARD-Heart. (European Union's Horizon 2020 research and innovation programme and EFPIA, IMI2-CARDIATEAM, European Union Commission's Seventh Framework programme|305507, HORIZON-EIC-2022-PATHFINDERCHALLENGES 01 'CARDIOGENOMICS', HORIZON European Innovation Council Grants, Innovative Medicines Initiative 2 Joint Undertaking|821508, DCM NEXT, Dutch Research Council Open Call ZonMW-Metacor, European Commission|101115416)